アブストラクト | Introduction: Macrolides, linezolid, imipenem-cilastatin, fluoroquinolones, penicillin combinations, and ceftriaxone are known to be associated with Torsades de pointes/QT prolongation (TdP/QTP). Other antibiotics may also lead to TdP/QTP, but no study has systemically compared TdP/QTP associations for many available antibiotics. Objectives: The objective of this study was to evaluate the association between TdP/QTP and many available antibiotics using the FDA Adverse Event Report System (FAERS). Methods: FAERS reports from January 1, 2015 to December 31, 2017 were analyzed. The Medical Dictionary for Regulatory Activities (MedDRA) was used to identify TdP/QTP cases. We calculated the Reporting Odds Ratios (RORs) and corresponding 95% confidence intervals (95%CI) for the association between antibiotics and TdP/QTP. An association was considered to be statistically significant when the lower limit of the 95%CI was greater than 1.0. Results: A total of 2,042,801 reports (including 3,960 TdP/QTP reports) were considered, after inclusion criteria were applied. Macrolides had the greatest proportion of TdP/QTP reports. Of the 4,092 reports associated with macrolides, 108 reports (2.6%) were associated with TdP/QTP. Significant TdP/QTP RORs (95%CI) for the antibiotics were (in descending order): macrolides 14.32 (11.80-17.38), linezolid 12.41 (8.52-18.08), amikacin 11.80 (5.57-24.97), imipenem-cilastatin 6.61 (3.13-13.94), fluoroquinolones 5.68 (4.78-6.76), penicillin combinations 3.42 (2.35-4.96), and ceftriaxone 2.55 (1.41-4.62). Conclusion: This study confirms prior evidence for TdP/QTP associations with macrolides, linezolid, imipenem-cilastatin, fluoroquinolones, penicillin combinations, and ceftriaxone. This study also identifies a new association between amikacin and TdP/QTP. |
ジャーナル名 | International journal of medical sciences |
Pubmed追加日 | 2019/7/26 |
投稿者 | Teng, Chengwen; Walter, Elizabeth A; Gaspar, Daryl Kevin S; Obodozie-Ofoegbu, Obiageri O; Frei, Christopher R |
組織名 | Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin,;San Antonio, TX, USA.;Pharmacotherapy Education and Research Center, Long School of Medicine,;University of Texas Health-San Antonio, San Antonio, TX, USA.;Division of Infectious Diseases, Long School of Medicine, University of Texas;Health-San Antonio, San Antonio, TX, USA.;South Texas Veterans Health Care System, San Antonio, TX, USA.;University Health System, San Antonio, TX, USA. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/31341415/ |